✦ LIBER ✦

Fluoxetine for the Treatment of Childhood Anxiety Disorders: Open-Label, Long-Term Extension to a Controlled Trial

✍ Scribed by CLARK, DUNCAN B.; BIRMAHER, BORIS; AXELSON, DAVID; MONK, KELLY; KALAS, CATHERINE; EHMANN, MARY; BRIDGE, JEFFREY; WOOD, D. SCOTT; MUTHEN, BENGT; BRENT, DAVID

Book ID: 125426557
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 130 KB
Volume: 44
Category: Article
ISSN: 1527-5418
DOI: 10.1097/01.chi.0000183464.41777.c1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-131 - Long term study of pregabalin fo

P-131 - Long term study of pregabalin for the treatment of generalized anxiety disorder: a 1 year open-label extension

✍ S. Montgomery; R. Prieto; B. Emir; H. Haswell 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 92 KB

Poster #176 LONG-TERM EFFECTS (UP TO 4 Y

Poster #176 LONG-TERM EFFECTS (UP TO 4 YEARS) OF ARIPIPRAZOLE ON MAINTENANCE TREATMENT FOR SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER: A POOLED OPEN-LABEL EXTENSION OF TWO CLINICAL TRIALS

✍ Ross A. Baker; Na Jin; Mirza W. Ali; Robert A. Forbes; Steven J. Offord; William 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Feasibility of Exercise Training for the

Feasibility of Exercise Training for the Short-Term Treatment of Generalized Anxiety Disorder: A Randomized Controlled Trial

✍ Herring, Matthew P.; Jacob, Marni L.; Suveg, Cynthia; Dishman, Rodney K.; O’Conn 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 202 KB

Quetiapine as an adjunctive pharmacother

Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial

✍ M.A. Katzman; M. Vermani; L. Jacobs; M. Marcus; B. Kong; S. Lessard; W. Galarrag 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Long-term safety and efficacy of ABT-874

Long-term safety and efficacy of ABT-874 for the treatment of moderate to severe psoriasis: Interim analysis from an open-label extension study

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Long-term efficacy and safety of inflixi

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three-month, randomized, placebo-controlled trial

✍ J. Braun; J. Brandt; J. Listing; A. Zink; R. Alten; G. Burmester; W. Golder; E. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 2 views